Therapy News and Research

RSS

AI tool effectively detects distress in hospital workers' conversations

An artificial intelligence tool effectively detected distress in hospital workers' conversations with their therapists early in the pandemic, a new study shows, suggesting a potential new technology that screens for depression and anxiety.

24 Oct 2023

Gene therapy breakthrough: Scientists develop method to deliver larger genes to target cells

Gene therapy currently represents the most promising approach for the treatment of hereditary diseases. Yet despite significant breakthroughs in recent years, there are still a number of hurdles that hinder the wider application of gene therapies.

24 Oct 2023

Older adults from disadvantaged communities less likely to attend cardiac rehabilitation after heart procedures

Older adults who live in disadvantaged communities are less likely to attend cardiac rehabilitation after common heart procedures, a Michigan Medicine-led study finds.

24 Oct 2023

Viral rebound common in lung transplant recipients treated with nirmatrelvir/ritonavir for COVID-19

Data on the viral rebound and safety of nirmatrelvir/ritonavir in lung transplant (LTx) recipients are limited.

24 Oct 2023

HIF-2α inhibitor belzutifan significantly reduces progression of clear cell renal cell carcinoma

Belzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer, in patients previously treated with immune checkpoint inhibitors and anti-angiogenic therapies compared with everolimus in a phase 3 clinical trial.

24 Oct 2023

Psychologists warn about the dangers of rising psychological pseudoscience

A rise in psychological pseudoscience is putting people at risk, psychologists have warned, with social media and celebrity endorsements partly to blame.

24 Oct 2023

Perioperative durvalumab may change standard-of-care for patients with resectable lung cancer

A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared to chemotherapy alone for patients with operable non-small cell lung cancer (NSCLC), according to results of a Phase III trial reported by researchers at The University of Texas MD Anderson Cancer Center.

24 Oct 2023

AI-assisted smartphone app performs well in skin cancer diagnosis

Artificial intelligence (AI) is already widely used in medical diagnostics. An Austrian-Australian research team led by dermatologist Harald Kittler from MedUni Vienna investigated the extent to which diagnosis and therapy of pigmented skin lesions benefit from it in a realistic clinical scenario.

24 Oct 2023

Finding and targeting dormant tumor cells to prevent breast cancer recurrence

While breast cancer survival continues to improve, thanks to advances in detection and treatment, when breast cancer recurs – or returns after initial treatment – it is incurable.

24 Oct 2023

Researchers discover new way to trigger programmed cell death in cancer cells

A research team from the UC Davis Comprehensive Cancer Center has identified a crucial epitope (a protein section that can activate the larger protein) on the CD95 receptor that can cause cells to die.

24 Oct 2023

Neoadjuvant pembrolizumab achieves major pathologic response in more than half of patients with resectable melanoma

In exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major pathologic response in more than half of surgical specimens taken from patients who had been treated with neoadjuvant (pre-operative) pembrolizumab.

24 Oct 2023

Study sheds light on role of gut fungi in severe COVID-19 and long COVID

Certain gut-dwelling fungi flourish in severe cases of COVID-19, amplifying the excessive inflammation that drives this disease while also causing long-lasting changes in the immune system, according to a new study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian.

24 Oct 2023

New "pseudo cell" formulation could revolutionize treatment of vitreoretinal diseases

Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences and Beijing Chaoyang Hospital have developed a new "pseudo cell" formulation based on self-healing microcapsule-loading exosomes to treat diverse vitreoretinal diseases.

24 Oct 2023

Therapy News and Research

AI tool effectively detects distress in hospital workers' conversations

Gene therapy breakthrough: Scientists develop method to deliver larger genes to target cells

Older adults from disadvantaged communities less likely to attend cardiac rehabilitation after heart procedures

Viral rebound common in lung transplant recipients treated with nirmatrelvir/ritonavir for COVID-19

HIF-2α inhibitor belzutifan significantly reduces progression of clear cell renal cell carcinoma

Psychologists warn about the dangers of rising psychological pseudoscience

Perioperative durvalumab may change standard-of-care for patients with resectable lung cancer

AI-assisted smartphone app performs well in skin cancer diagnosis

Finding and targeting dormant tumor cells to prevent breast cancer recurrence

Researchers discover new way to trigger programmed cell death in cancer cells

Neoadjuvant pembrolizumab achieves major pathologic response in more than half of patients with resectable melanoma

Study sheds light on role of gut fungi in severe COVID-19 and long COVID

New "pseudo cell" formulation could revolutionize treatment of vitreoretinal diseases

Utilizing Biomarkers in Cancer Prevention, Diagnosis, and Treatment

AI-powered ECG tool supports the detection of heart disease

Researchers receive $3.6 million to test novel diagnosis and treatment combination for diabetic neuropathy

The intricate interplay of stress, quality of life, and gut microbiota in newly diagnosed breast cancer patients

Resistant potato starch usage found to be feasible and safe for hematopoietic stem cell transplantation patients

Lactobacillus iners in tumors: Driving chemoradiation resistance via lactate-induced metabolic rewiring

Study shows TAVR as a good alternative to open-heart surgery in younger patients with aortic stenosis

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News